C

Cidara Therapeutics

CDTX

12.890
USD
-0.19
(-1.45%)
Market Open
Volume
20
EPS
0
Div Yield
0
P/E
-0
Market Cap
78,124,475
Related Instruments
ABBV
4.380
(2.36%)
189.700 USD
AZN
2.040
(2.58%)
81.200 USD
BMY
0.620
(1.30%)
48.180 USD
GILD
0.470
(0.62%)
76.510 USD
GSK
0.865
(2.23%)
39.650 USD
JNJ
2.930
(1.86%)
160.770 USD
LLY
28.47
(3.54%)
832.74 USD
MRK
0.680
(0.60%)
113.800 USD
PFE
0.115
(0.38%)
30.650 USD
News

Title: Cidara Therapeutics

Sector: Healthcare
Industry: Biotechnology
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak(R) platform targeting oncologic, viral and autoimmune diseases.